approach includes targeting the accumulation of specific proteins in the brain, which are associated with the progression of neurodegenerative diseases. DaCapo Brainscience is committed to advancing research and development to offer new paths forward for patients affected by these conditions. The team consists of professionals with extensive experience in biotechnology, working towards making significant contributions to the field of neuroscience.